These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2021954)

  • 1. Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking.
    Ramakrishna V; Shinitzky M
    Cancer Immunol Immunother; 1991; 33(1):1-8. PubMed ID: 2021954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine.
    Goldman Y; Peled A; Shinitzky M
    Cancer Res; 2000 Jan; 60(2):350-8. PubMed ID: 10667587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto-delayed-type hypersensitivity induced in immunodeficient mice with syngeneic modified self-antigens. II. Suppressor T cells control the autoimmune response.
    Tarcic N; Sharon R; Rosenmann E; Naor D
    Scand J Immunol; 1984 Feb; 19(2):111-21. PubMed ID: 6230714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.
    Eisenthal A; Ramakrishna V; Skornick Y; Shinitzky M
    Cancer Immunol Immunother; 1993 May; 36(5):300-6. PubMed ID: 8477416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor cells, modified by a novel pressure/crosslinking methodology, promote autologous lymphocyte proliferation and modulate cytokine secretion.
    Eisenthal A; Goldman Y; Skornick Y; Gelfand A; Buyaner D; Kaver I; Yellin A; Yehoshua H; Lifschitz-Mercer B; Gonnene A; Shinitzky M
    Cancer Immunol Immunother; 1998 Aug; 46(6):304-10. PubMed ID: 9756414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Dec; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract]   [Full Text] [Related]  

  • 10. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity.
    Zangemeister-Wittke U; Kyewski B; Schirrmacher V
    J Immunol; 1989 Jul; 143(1):379-85. PubMed ID: 2499633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.
    Szczepanik M; Akahira-Azuma M; Bryniarski K; Tsuji RF; Kawikova I; Ptak W; Kiener C; Campos RA; Askenase PW
    J Immunol; 2003 Dec; 171(11):6225-35. PubMed ID: 14634139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. III. Suppressive T-cell factor controls the autoreactivity against self-antigens.
    Tarcic N; Baler R; Naor D
    Scand J Immunol; 1984 Nov; 20(5):389-401. PubMed ID: 6239370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
    Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
    Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity induced in immunodeficient mice with syngeneic modified self antigens: a suggestive model of autoimmune response.
    Tarcic N; Naor D
    Eur J Immunol; 1982 Nov; 12(11):961-6. PubMed ID: 6983970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of autoimmune responses induced with modified self antigens.
    Naor D; Tarcic N
    Ann N Y Acad Sci; 1982; 392():178-90. PubMed ID: 6215878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of anti-tumor effects of lentinan in nude mice: roles of delayed-type hypersensitivity reaction triggered by CD4-positive T cell clone in the infiltration of effector cells into tumor.
    Suzuki M; Iwashiro M; Takatsuki F; Kuribayashi K; Hamuro J
    Jpn J Cancer Res; 1994 Apr; 85(4):409-17. PubMed ID: 7911123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
    Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.